A Mindfulness-based Intervention for Older Women With Low Sexual Desire

October 11, 2022 updated by: Holly Thomas, University of Pittsburgh
The overall aim of this research is to adapt and pilot test a multi-component, mindfulness-based behavioral intervention for women age 50 and older with low sexual desire.

Study Overview

Detailed Description

Specifically, the investigators will conduct a pilot randomized controlled trial to assess the feasibility, acceptability, and preliminary efficacy of the intervention. Fifty women will be randomized to the mindfulness intervention or an educational control group. Both groups will be conducted in 3 sessions over 6 weeks in groups of 10 women. Feasibility, acceptability, facilitators, and barriers will be assessed by surveys after each session and after intervention completion. Preliminary efficacy will be assessed by measures of sexual desire, sexual function, and overall sexual satisfaction at 6 and 12 weeks.

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • University of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • meet criteria for a diagnosis of Female Sexual Interest/Arousal Disorder
  • English-speaking
  • have a current sexual partner with whom they are or would like to be sexually active

Exclusion Criteria:

  • active major depression
  • active substance abuse
  • current intimate partner violence
  • partner with active major depression
  • partner with active major substance abuse
  • significant relationship dissatisfaction
  • current use of antidepressants
  • untreated dyspareunia (sexual pain)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: mindfulness group
A multicomponent group-based intervention rooted in mindfulness, administered in 3 sessions over 6 weeks
A group-based, multicomponent behavioral intervention rooted in mindfulness
ACTIVE_COMPARATOR: educational group
A general midlife health and aging educational group, administered in 3 sessions over 6 weeks
A general health and aging education group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility - Number of Enrolled Women Participating in All Sessions
Time Frame: 6 weeks
Number of enrolled women participating in all sessions
6 weeks
Acceptability - Number of Women Indicating "Somewhat" or "Very Satisfied" on a 5-point Likert Scale Measure of Intervention Satisfaction
Time Frame: 6 weeks
Number of women indicating "somewhat" or "very satisfied" on a 5-point Likert scale measure of intervention satisfaction
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in FSFI Desire Score
Time Frame: Baseline and 12 weeks
Change in Female Sexual Function Index (FSFI) desire score from baseline to 12 weeks. The FSFI Desire score is a subscale of the FSFI. Scores range from 1.0 to 5.0, with higher scores indicating worse sexual desire. Minimum score is 1.0 and maximum score is 5.0.
Baseline and 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Overall Sexual Function
Time Frame: Baseline and 12 weeks
Total Female Sexual Function Index (FSFI) score from baseline to 12 weeks. The FSFI score can range from 2.0 to 36.0, and a higher score indicates worse sexual function.
Baseline and 12 weeks
Comprehensive Sexual Desire
Time Frame: 6 weeks and 12 weeks
Sexual Interest and Desire Inventory (SIDI)
6 weeks and 12 weeks
Sexual Distress
Time Frame: 6 weeks and 12 weeks
Female Sexual Distress Scale - Revised (FSDS-R)
6 weeks and 12 weeks
Quality of Life - SF 36
Time Frame: 6 weeks and 12 weeks
Quality of life as measured by Short Form-36 (SF-36)
6 weeks and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 8, 2020

Primary Completion (ACTUAL)

September 1, 2021

Study Completion (ACTUAL)

September 1, 2021

Study Registration Dates

First Submitted

March 10, 2017

First Submitted That Met QC Criteria

July 25, 2017

First Posted (ACTUAL)

July 28, 2017

Study Record Updates

Last Update Posted (ACTUAL)

October 13, 2022

Last Update Submitted That Met QC Criteria

October 11, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Dysfunction

Clinical Trials on mindfulness-based multicomponent intervention

Subscribe